ARANESP 30 mcg a système protection ser pré 4 pce
7680557250580
CH-55725
B03XA02
06.07.3.
Reimbursement limitations:
ARANESP4
Anémie rénale lors d'une insuffisance rénale: 17807.1
Le code d’indication suivant doit être transmis: 17807.1
…
1 / 3
google
Details
- Product number
- 5572504
- CPT
- -
- Packaging group
- 4
- Unit
- Spritze(n)
- Composition
- darbepoetinum alfa 30 µg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.3 ml corresp., natrium 1.14 mg.
Articles (1)
Aranesp 30 Mikrogramm, Injektionslösung in Fertigspritze
Injektionslösung in Fertigspritze
4
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
30.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.14 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 292.90
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2002
Authorization holder
Amgen Switzerland AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 55725
- Drug name
- Aranesp, Injektionslösung in Fertigspritze
- Galenic form
- INLFS
- ATC Code
- B03XA02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 13/09/2002
- Authorization expiration date
- 31/12/9999
- IT number
- 06.07.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ARANESP 30 mcg a système protection ser pré 4 pce
- Description (DE)
- ARANESP 30 mcg m Nadelschutz Fertspr 4 Stk
- Market launch
- 13/09/2002
- Narcotic (BTM)
- No